ABEO - Abeona Therapeutics Inc.
| Previous Close | 2.7600 |
| Open | 2.8100 |
| Bid | 3.0200 x 1300 |
| Ask | 3.1000 x 1000 |
| Day's Range | 2.5900 - 3.0400 |
| 52 Week Range | 1.4600 - 9.5500 |
| Volume | 1,668,023 |
| Avg. Volume | 560,200 |
| Market Cap | 153.463M |
| Beta (3Y Monthly) | 2.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.5900 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.20 |
- ACCESSWIRE
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 6, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abeona Therapeutics Inc. ("Abeona" ...
- GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO
Pomerantz LLP announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New York, and docketed under 19-cv-10181, is on behalf of a class consisting of investors who purchased or otherwise acquired Abeona securities between May 31, 2018 and September 23, 2019, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Bloom Energy Corporation (BE)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
- Newsfile
Abeona Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - December 6, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Abeona Therapeutics Inc. (NASDAQ: ABEO) ("Abeona" or the "Company") of the December 31, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Abeona stock or options between May 31, 2018 ...
- GlobeNewswire
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO
NEW YORK, Dec. 05, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abeona Therapeutics Inc. (NASDAQ: ABEO) between May 31,.
- Newsfile
Abeona Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - December 5, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Abeona Therapeutics Inc. (NASDAQ: ABEO) ("Abeona" or the "Company") of the December 31, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Abeona stock or options between May 31, 2018 ...
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ABEO
NEW YORK, NY / ACCESSWIRE / December 4, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. ("Abeona" or the "Company") (ABEO) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New York, and docketed under 19-cv-10181, is on behalf of a class consisting of investors who purchased or otherwise acquired Abeona securities between May 31, 2018 and September 23, 2019, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Abeona, AZZ, Under Armour, and UP Fintech and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Abeona Therapeutics, Inc. (ABEO), AZZ, Inc. (AZZ), Under Armour, Inc. (NYSE: UA, UAA), and UP Fintech Holding Limited (TIGR). From preliminary clinical data and expert input, the Company expected EB-101 to be a potential treatment choice for most wounds, and believes it is currently the only product candidate being evaluated as a treatment for larger wounds. On September 23, 2019, Abeona issued a press release announcing receipt of a clinical hold letter from the FDA, “clarifying that the FDA will not provide approval for the Company to begin its planned Phase 3 clinical trial for EB-101 [a/k/a, the VITAL Study] until it submits to the FDA additional data points on transport stability of EB-101 to clinical sites” (the “September 2019 Press Release”).
- Newsfile
Abeona Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - December 4, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Abeona Therapeutics Inc. (NASDAQ: ABEO) ("Abeona" or the "Company") of the December 31, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Abeona stock or options between May 31, ...
- Thomson Reuters StreetEvents
Edited Transcript of ABEO earnings conference call or presentation 13-Nov-19 3:00pm GMT
Q3 2019 Abeona Therapeutics Inc Earnings Call
- ACCESSWIRE
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 2, 2019 / The Schall Law Firm ,a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Abeona Therapeutics Inc. ("Abeona" ...
- Simply Wall St.
We're A Little Worried About Abeona Therapeutics's (NASDAQ:ABEO) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Bloom Energy Corporation (BE)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
- GlobeNewswire
ABEO NOTICE: Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.– ABEO
Pawar Law Group announces that a class action lawsuit on behalf of shareholders who purchased shares of Abeona Therapeutics Inc. (ABEO) from May 31, 2018 through September 23, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Abeona Therapeutics Inc. investors under the federal securities laws. A class action lawsuit has already been filed.
- GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sealed Air, Abeona, AZZ, and Under Armour and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Sealed Air Corporation (SEE), Abeona Therapeutics, Inc. (ABEO), AZZ, Inc. (AZZ), and Under Armour, Inc. (NYSE: UA, UAA). On November 5, 2014 Sealed Air filed its quarterly report on Form 10-Q for the quarter ended September 30, 2014, which was signed by defendant Stiehl and contained signed certifications by defendants Peribere and Lowe stating that the statements contained therein were accurate and not materially misleading. The Form 10-Q stated that Sealed Air had achieved $59.3 million in net earnings for the quarter.
- GlobeNewswire
ROSEN, A GLOBAL LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO
NEW YORK, Nov. 25, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abeona Therapeutics Inc. (NASDAQ: ABEO) between May 31,.
- ACCESSWIRE
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO), AZZ, Inc. (AZZ) & Bloom Energy Corporation (BE)
NEW YORK, NY / ACCESSWIRE / November 25, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can ...
